Open AccessSleep‐disordered breathing in heart failure: facts and numbers
Author(s) -
Pietrock Charlotte,
Haehling Stephan
Publication year - 2017
Publication title -
esc heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.787
H-Index - 25
ISSN - 2055-5822
DOI - 10.1002/ehf2.12193
Subject(s) - medicine , polysomnography , breathing , heart failure , sleep disordered breathing , positive airway pressure , continuous positive airway pressure , sleep and breathing , population , ventilation (architecture) , gold standard (test) , intensive care medicine , sleep (system call) , cardiology , anesthesia , apnea , obstructive sleep apnea , environmental health , computer science , engineering , operating system , mechanical engineering
Sleep‐disordered breathing has a high prevalence in the general population, but is especially prominent in patients with heart failure (HF). HF and sleep‐disordered breathing share a bidirectional relationship, with sleep‐disordered breathing being both cause and effect of poor cardiac functioning. The high inter‐individual variability of symptom presentation can impede the clinical diagnostic process. Polysomnography is the gold‐standard method of diagnosing sleep‐disordered breathing. Therapy of sleep‐disordered breathing should always consist of optimizing the treatment of the underlying disorder of HF. Additional therapeutic measures include continuous positive airway pressure ventilation therapy. New therapeutic options using neurostimulation are yielding promising results; however, long‐term benefits still need to be confirmed.